4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole

C182H143N7O4 — CID 158116724

IUPAC4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole
SMILESCC1(C)CN=C(c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)c3ccccc23)O1.CC1(C)COC(c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)c3ccccc23)=N1.CC1(C)N=C(c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)c3ccccc23)OC1(C)C.CC1(C)N=C(c2ccccc2)N(c2cccc(-c3c4ccccc4c(-c4cccc5ccccc45)c4ccccc34)n2)C1(C)C.c1ccc(-c2c3ccccc3c(-c3ccc(C4=NCCO4)c4ccccc34)c3ccccc23)cc1
InChIInChI=1S/C42H35N3.C37H31NO.2C35H27NO.C33H23NO/c1-41(2)42(3,4)45(40(44-41)29-17-6-5-7-18-29)37-27-15-26-36(43-37)39-34-23-12-10-21-32(34)38(33-22-11-13-24-35(33)39)31-25-14-19-28-16-8-9-20-30(28)31;1-36(2)37(3,4)39-35(38-36)32-23-22-31(25-16-8-9-17-26(25)32)34-29-20-12-10-18-27(29)33(24-14-6-5-7-15-24)28-19-11-13-21-30(28)34;1-35(2)22-37-34(36-35)31-21-20-30(24-14-6-7-15-25(24)31)33-28-18-10-8-16-26(28)32(23-12-4-3-5-13-23)27-17-9-11-19-29(27)33;1-35(2)22-36-34(37-35)31-21-20-30(24-14-6-7-15-25(24)31)33-28-18-10-8-16-26(28)32(23-12-4-3-5-13-23)27-17-9-11-19-29(27)33;1-2-10-22(11-3-1)31-25-14-6-8-16-27(25)32(28-17-9-7-15-26(28)31)29-18-19-30(33-34-20-21-35-33)24-13-5-4-12-23(24)29/h5-27H,1-4H3;5-23H,1-4H3;2*3-21H,22H2,1-2H3;1-19H,20-21H2
InChIKeyFRCGQHAIYYMAKU-UHFFFAOYSA-N
MW2492.19 g/mol
LogP46.84
Rot. Bonds16

About 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole

4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole (PubChem CID 158116724) has the molecular formula C182H143N7O4 and a molecular weight of 2492.19 g/mol. Its IUPAC name is 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole.

Molecular Properties

Compound Name4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole
PubChem CID158116724
Molecular FormulaC182H143N7O4
Molecular Weight2492.19 g/mol
Exact Mass2490.12
IUPAC Name4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole
SMILESCC1(C)CN=C(c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)c3ccccc23)O1.CC1(C)COC(c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)c3ccccc23)=N1.CC1(C)N=C(c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)c3ccccc23)OC1(C)C.CC1(C)N=C(c2ccccc2)N(c2cccc(-c3c4ccccc4c(-c4cccc5ccccc45)c4ccccc34)n2)C1(C)C.c1ccc(-c2c3ccccc3c(-c3ccc(C4=NCCO4)c4ccccc34)c3ccccc23)cc1
InChIInChI=1S/C42H35N3.C37H31NO.2C35H27NO.C33H23NO/c1-41(2)42(3,4)45(40(44-41)29-17-6-5-7-18-29)37-27-15-26-36(43-37)39-34-23-12-10-21-32(34)38(33-22-11-13-24-35(33)39)31-25-14-19-28-16-8-9-20-30(28)31;1-36(2)37(3,4)39-35(38-36)32-23-22-31(25-16-8-9-17-26(25)32)34-29-20-12-10-18-27(29)33(24-14-6-5-7-15-24)28-19-11-13-21-30(28)34;1-35(2)22-37-34(36-35)31-21-20-30(24-14-6-7-15-25(24)31)33-28-18-10-8-16-26(28)32(23-12-4-3-5-13-23)27-17-9-11-19-29(27)33;1-35(2)22-36-34(37-35)31-21-20-30(24-14-6-7-15-25(24)31)33-28-18-10-8-16-26(28)32(23-12-4-3-5-13-23)27-17-9-11-19-29(27)33;1-2-10-22(11-3-1)31-25-14-6-8-16-27(25)32(28-17-9-7-15-26(28)31)29-18-19-30(33-34-20-21-35-33)24-13-5-4-12-23(24)29/h5-27H,1-4H3;5-23H,1-4H3;2*3-21H,22H2,1-2H3;1-19H,20-21H2
InChIKeyFRCGQHAIYYMAKU-UHFFFAOYSA-N
XLogP46.84
TPSA114.85 Ų
H-Bond Donors
H-Bond Acceptors11
Rotatable Bonds16
Heavy Atoms193
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002492.19
LogP ≤ 546.84
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-(4-Ethylpiperazin-1-yl)-3-[4-(2-benzyloxyethyl)phenyl]isoquinoline
CID 17794320
1-(4-Ethylpiperazin-1-yl)-3-[4-(oxolan-2-yl)phenyl]isoquinoline
CID 22503585
2-[4-[2-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole
CID 135249592
2-[4-[2-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-6-(3-phenylphenyl)pyrimidin-4-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole
CID 135250565
2-[4-[2-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-6-(3,5-diphenylphenyl)pyrimidin-4-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole
CID 135250572
2-[4-[6-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-2-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole
CID 135250594
2-[4-[6-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-2-(3-phenylphenyl)pyrimidin-4-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole
CID 135250599
2-[4-[6-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-2-(3,5-diphenylphenyl)pyrimidin-4-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole
CID 135250604
2-[4-[2-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole
CID 135250621
1-[6-[2-cyclohexa-1,3-dien-1-yl-6-(3-phenylphenyl)pyrimidin-4-yl]naphthalen-2-yl]ethyl N-methylbenzenecarboximidate
CID 155470542
4,4-dimethyl-2-[4-(10-naphthalen-1-ylanthracen-9-yl)phenyl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-naphthalen-1-ylanthracen-9-yl)phenyl]-4H-1,3-oxazole;2-[4-(10-naphthalen-1-ylanthracen-9-yl)phenyl]-4,5-dihydro-1,3-oxazole;2,4,4,5,5-pentamethyl-1-[3-(10-naphthalen-1-ylanthracen-9-yl)phenyl]imidazole;4,4,5,5-tetramethyl-1-[3-(10-naphthalen-1-ylanthracen-9-yl)phenyl]-2-phenylimidazole
CID 157950721
2-[4-[9-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]benzo[b]triphenylen-14-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[9-[4-(4,4-dimethyl-5H-1,3-thiazol-2-yl)phenyl]benzo[b]triphenylen-14-yl]phenyl]-4,4-dimethyl-5H-1,3-thiazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-5-[12-[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]benzo[a]anthracen-7-yl]pyridine;2,4,4,5,5-pentamethyl-1-[4-[9-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]benzo[b]triphenylen-14-yl]phenyl]imidazole;4,4,5,5-tetramethyl-1-phenyl-2-[4-[9-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]benzo[b]triphenylen-14-yl]phenyl]imidazole
CID 158440610

Frequently Asked Questions

What is the IUPAC name of 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole?
The IUPAC name of 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole (CID 158116724) is 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole.
What is the SMILES notation for 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole?
The canonical SMILES for 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole is CC1(C)CN=C(c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)c3ccccc23)O1.CC1(C)COC(c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)c3ccccc23)=N1.CC1(C)N=C(c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)c3ccccc23)OC1(C)C.CC1(C)N=C(c2ccccc2)N(c2cccc(-c3c4ccccc4c(-c4cccc5ccccc45)c4ccccc34)n2)C1(C)C.c1ccc(-c2c3ccccc3c(-c3ccc(C4=NCCO4)c4ccccc34)c3ccccc23)cc1.
What is the InChIKey of 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole?
The InChIKey is FRCGQHAIYYMAKU-UHFFFAOYSA-N. The full InChI is InChI=1S/C42H35N3.C37H31NO.2C35H27NO.C33H23NO/c1-41(2)42(3,4)45(40(44-41)29-17-6-5-7-18-29)37-27-15-26-36(43-37)39-34-23-12-10-21-32(34)38(33-22-11-13-24-35(33)39)31-25-14-19-28-16-8-9-20-30(28)31;1-36(2)37(3,4)39-35(38-36)32-23-22-31(25-16-8-9-17-26(25)32)34-29-20-12-10-18-27(29)33(24-14-6-5-7-15-24)28-19-11-13-21-30(28)34;1-35(2)22-37-34(36-35)31-21-20-30(24-14-6-7-15-25(24)31)33-28-18-10-8-16-26(28)32(23-12-4-3-5-13-23)27-17-9-11-19-29(27)33;1-35(2)22-36-34(37-35)31-21-20-30(24-14-6-7-15-25(24)31)33-28-18-10-8-16-26(28)32(23-12-4-3-5-13-23)27-17-9-11-19-29(27)33;1-2-10-22(11-3-1)31-25-14-6-8-16-27(25)32(28-17-9-7-15-26(28)31)29-18-19-30(33-34-20-21-35-33)24-13-5-4-12-23(24)29/h5-27H,1-4H3;5-23H,1-4H3;2*3-21H,22H2,1-2H3;1-19H,20-21H2.
What are the key properties of 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole?
4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole has a molecular weight of 2492.19 g/mol, XLogP of 46.84, 16 rotatable bonds, 0 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 4,4-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-5H-1,3-oxazole;5,5-dimethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4H-1,3-oxazole;2-(10-naphthalen-1-ylanthracen-9-yl)-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine;2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[4-(10-phenylanthracen-9-yl)naphthalen-1-yl]-1,3-oxazole is sourced from PubChem (CID 158116724), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).